Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B

Conventional treatment of chronic hepatitis B (CHB) is rarely curative due to the immunotolerant status of patients. RG7854 is an oral double prodrug of a toll-like receptor 7 (TLR7) agonist that is developed for the treatment of CHB. The therapeutic efficacy, host immune response, and safety of RG7...

Descripción completa

Detalles Bibliográficos
Autores principales: Wildum, Steffen, Korolowicz, Kyle E., Suresh, Manasa, Steiner, Guido, Dai, Lue, Li, Bin, Yon, Changsuek, De Vera Mudry, Maria Cristina, Regenass-Lechner, Franziska, Huang, Xu, Hong, Xupeng, Murreddu, Marta G., Kallakury, Bhaskar V., Young, John A. T., Menne, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169629/
https://www.ncbi.nlm.nih.gov/pubmed/35677037
http://dx.doi.org/10.3389/fimmu.2022.884113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169629/
https://www.ncbi.nlm.nih.gov/pubmed/35677037
http://dx.doi.org/10.3389/fimmu.2022.884113

Ejemplares similares